We are live on ! Find out more
VERV

Verve Therapeutics
VERV

Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

6 hedge funds and large institutions have $1.24M invested in Verve Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

81.59% less ownership

Funds ownership: 81.84% → 0.26% (-82%)

97% less funds holding

Funds holding: 175 → 6 (-169)

100% less capital invested

Capital invested by funds: $819M → $1.24M (-$818M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 169

Holders
6
Holders Change
-169
Holders Change %
-96.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
169
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$955K
2
IA
IFP Advisors
Florida
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
-$137M
2
BlackRock
BlackRock
New York
-$82.6M
3
PCM
Pentwater Capital Management
Florida
-$75.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$47.1M
5
CC
Casdin Capital
New York
-$46M
Name Holding Trade Value Shares
Change 		Change in
Stake
B
101
Bailard
California
– -$256K -22,800 Closed
HighTower Advisors
102
HighTower Advisors
Illinois
– -$227K -20,237 Closed
HL
103
HeadInvest LLC
Maine
– -$225K -20,000 Closed
BAM
104
Blueshift Asset Management
New Jersey
– -$219K -19,483 Closed
VOYA Investment Management
105
VOYA Investment Management
Georgia
– -$213K -18,937 Closed
EGM
106
Engineers Gate Manager
New York
– -$205K -18,256 Closed
CUAMC
107
China Universal Asset Management Company
China
– -$201K -17,904 Closed
PCM
108
Polymer Capital Management
New York
– -$201K -17,854 Closed
MSFS
109
Main Street Financial Solutions
Pennsylvania
– -$193K -17,211 Closed
ASRS
110
Arizona State Retirement System
Arizona
– -$189K -16,827 Closed
PA
111
Profund Advisors
Maryland
– -$182K -16,210 Closed
Creative Planning
112
Creative Planning
Kansas
– -$178K -15,837 Closed
SC
113
Syon Capital
California
– -$178K -15,830 Closed
PFSRSONJ
114
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$176K -15,673 Closed
Teacher Retirement System of Texas
115
Teacher Retirement System of Texas
Texas
– -$175K -15,627 Closed
Royal Bank of Canada
116
Royal Bank of Canada
Ontario, Canada
– -$176K -15,615 Closed
Bank of Montreal
117
Bank of Montreal
Ontario, Canada
– -$174K -15,456 Closed
Carson Wealth (CWM LLC)
118
Carson Wealth (CWM LLC)
Nebraska
– -$172K -15,352 Closed
Janus Henderson Group
119
Janus Henderson Group
United Kingdom
– -$169K -15,031 Closed
VIA
120
Virtus Investment Advisers
Connecticut
– -$167K -14,879 Closed
BHCM
121
Brevan Howard Capital Management
Jersey
– -$166K -14,754 Closed
IC
122
IEQ Capital
California
– -$164K -14,648 Closed
State Board of Administration of Florida Retirement System
123
State Board of Administration of Florida Retirement System
Florida
– -$163K -14,490 Closed
NSEDCP
124
NJ State Employees Deferred Compensation Plan
New Jersey
– -$157K -14,000 Closed
CL
125
CSS LLC
Illinois
– -$155K -13,825 Closed
3 4
5
6 7

VERV Hedge Fund Activity: Q3 2025 in Review

6 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q3 2025, worth a combined $1.24M — down 100% from $819M a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of VERV and 0 opened new positions — a net loss of 169 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $955K. The largest seller was Alphabet Inc, exiting entirely with an estimated $137M sold.

  • 6 institutional investors held Verve Therapeutics (VERV) as of Q3 2025, down from 175 in Q2 2025.
  • Funds reported $1.24M of Verve Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Verve Therapeutics positions in Q3 2025 and 169 closed out, a net change of -169 holders.
  • The largest Verve Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $955K added.
  • The largest Verve Therapeutics seller in Q3 2025 was Alphabet Inc, an estimated $137M sold.

Based on aggregated 13F filings for Q3 2025.